Pfizer and BioNTech submit data they say show shots are safe in 5- to 11-year-olds.

The companies said that they would submit a formal request to regulators to allow a pediatric dose of their vaccine to be administered in the United States in the coming weeks.
By Sharon LaFraniere, Shashank Bengali and Noah Weiland from NYT U.S. https://ift.tt/3kQDSJi
via IFTTT